These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27349173)

  • 1. In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.
    Li S; Wu L; Feng J; Li J; Liu T; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Kong R; Chen K; Wang F; Xia Y; Lu J; Zhou Y; Dai W; Guo C
    Sci Rep; 2016 Jun; 6():28479. PubMed ID: 27349173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
    Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C
    Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
    Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
    J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation.
    Kaufmann R; Henklein P; Henklein P; Settmacher U
    Oncol Rep; 2009 May; 21(5):1261-7. PubMed ID: 19360302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
    Huang W; Ding L; Huang Q; Hu H; Liu S; Yang X; Hu X; Dang Y; Shen S; Li J; Ji X; Jiang S; Liu JO; Yu L
    Hepatology; 2010 Aug; 52(2):703-14. PubMed ID: 20683966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
    Shen X; Zhang Y; Feng Y; Zhang L; Li J; Xie YA; Luo X
    Int J Oncol; 2014 Mar; 44(3):791-6. PubMed ID: 24402647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
    Yang H; Wang M; Sun H; Zhu S; Jin J
    Pharmacology; 2019; 104(5-6):267-275. PubMed ID: 31434088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
    Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
    J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals.
    Abou El Naga RN; Azab SS; El-Demerdash E; Shaarawy S; El-Merzabani M; Ammar el-SM
    Life Sci; 2013 Mar; 92(10):555-61. PubMed ID: 23352978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
    Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
    Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
    He L; Peng L; Wang L; Jiang X; Sun X; Li H; Lin T; Wu Z; Lin S
    Biochem Biophys Res Commun; 2024 Jun; 714():149976. PubMed ID: 38677007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study.
    Sabry D; Abdelaleem OO; El Amin Ali AM; Mohammed RA; Abdel-Hameed ND; Hassouna A; Khalifa WA
    Mol Biol Rep; 2019 Apr; 46(2):2039-2047. PubMed ID: 30710234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.
    Farhan M; Rizvi A; Naseem I; Hadi SM; Ahmad A
    Tumour Biol; 2015 Nov; 36(11):8861-7. PubMed ID: 26069106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
    Tsang WP; Kwok TT
    J Nutr Biochem; 2010 Feb; 21(2):140-6. PubMed ID: 19269153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
    Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
    Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
    Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS
    Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.